These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8096126)

  • 21. Metabolism of an antiallergic agent, azelastine (4-(p-chlorobenzyl)-2-[N-methylperhydroazepinyl-(4)]-1-(2H)-p hthalazin one hydrochloride) in rats and guinea pigs.
    Tatsumi K; Yamada H; Yoshimura H; Nishizawa Y; Sakai M; Mizuo H; Yamato C
    Hiroshima J Med Sci; 1984 Dec; 33(4):669-78. PubMed ID: 6152559
    [No Abstract]   [Full Text] [Related]  

  • 22. Determination of azelastine and desmethylazelastine in human plasma by high-performance liquid chromatography.
    Pivonka J; Segelman FH; Hartman CA; Segl WE; Kucharczyk N; Sofia RD
    J Chromatogr; 1987 Sep; 420(1):89-98. PubMed ID: 2889747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects.
    Riethmüller-Winzen H; Peter G; Büker KM; Romeis P; Borbe HO
    Arzneimittelforschung; 1994 Oct; 44(10):1136-40. PubMed ID: 7818588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of azelastine and its major metabolite desmethylazelastine in human plasma using high performance liquid chromatography-tandem mass spectrometry.
    Zha W; Shum L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 906():69-74. PubMed ID: 22954967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro characterisation of the duration of action of the histamine-1 receptor antagonist azelastine.
    Slack RJ; Hart AD; Luttmann MA; Clark KL; Begg M
    Eur J Pharmacol; 2011 Nov; 670(2-3):586-92. PubMed ID: 21946109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Azelastine inhibits bronchial hyperreactivity to acetylcholine in guinea pigs.
    Achterrath-Tuckermann U; Szelenyi I
    Experientia; 1988 Dec; 44(11-12):993-6. PubMed ID: 2904378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of azelastine hydrochloride on vascular permeability in hypersensitivity reaction skin site in guinea pig.
    Tanigawa T; Honda M; Miura K
    Arzneimittelforschung; 1981; 31(8):1212-5. PubMed ID: 6117291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteers.
    Morganroth J; Lyness WH; Perhach JL; Mather GG; Harr JE; Trager WF; Levy RH; Rosenberg A
    J Clin Pharmacol; 1997 Nov; 37(11):1065-72. PubMed ID: 9506001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes.
    Chand N; Pillar J; Diamantis W; Sofia RD
    Int Arch Allergy Appl Immunol; 1985; 77(4):451-5. PubMed ID: 2410374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-allergic effect of azelastine hydrochloride on immediate type hypersensitivity reactions in vivo and in vitro.
    Katayama S; Akimoto N; Shionoya H; Morimoto T; Katoh Y
    Arzneimittelforschung; 1981; 31(8):1196-203. PubMed ID: 6170298
    [No Abstract]   [Full Text] [Related]  

  • 32. The in vivo potency and selectivity of azelastine as an H1 histamine-receptor antagonist in human airways and skin.
    Rafferty P; Harrison PJ; Aurich R; Holgate ST
    J Allergy Clin Immunol; 1988 Dec; 82(6):1113-8. PubMed ID: 2904931
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of inhibitory effects of azelastine on smooth muscle contraction.
    Masuo M; Shimada T; Kitazawa T
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1300-8. PubMed ID: 1347567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of aeroallergen-induced bronchial eosinophilia by azelastine in guinea pigs.
    Chand N; Nolan K; Diamantis W; Sofia RD
    Int Arch Allergy Immunol; 1992; 97(3):229-32. PubMed ID: 1587636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of allergic and nonallergic leukotriene C4 formation and histamine secretion by azelastine: implication for its mechanism of action.
    Chand N; Pillar J; Nolan K; Diamantis W; Sofia RD
    Int Arch Allergy Appl Immunol; 1989; 90(1):67-70. PubMed ID: 2478485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages.
    Nakamura T; Nishizawa Y; Sato T; Yamato C
    Eur J Pharmacol; 1988 Mar; 148(1):35-41. PubMed ID: 2898372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies of metabolic fate of a new antiallergic agent, azelastine (4-(p-chlorobenzyl)-2-[N-methylperhydroazepinyl-(4)]-1-(2H)-phthalazinone hydrochloride).
    Tatsumi K; Ou T; Yamada H; Yoshimura H
    Jpn J Pharmacol; 1980 Feb; 30(1):37-48. PubMed ID: 6105223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of azelastine on microviscosity of bronchial lavage fluid obtained from actively sensitized and challenged guinea pigs.
    Achterrath-Tuckermann U; Motta C; Szelenyi I
    Agents Actions; 1989 Jan; 26(1-2):70-2. PubMed ID: 2565668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on the novel antiallergic agent HSR-609: its penetration into the central nervous system in mice and guinea pigs and its selectivity for the histamine H1-receptor.
    Kakiuchi M; Ohashi T; Musoh K; Kawamura K; Morikawa K; Kato H
    Jpn J Pharmacol; 1997 Apr; 73(4):291-8. PubMed ID: 9165365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preclinical pharmacology of desloratadine, a selective and nonsedating histamine H1 receptor antagonist. 1st communication: receptor selectivity, antihistaminic activity, and antiallergenic effects.
    Kreutner W; Hey JA; Anthes J; Barnett A; Young S; Tozzi S
    Arzneimittelforschung; 2000 Apr; 50(4):345-52. PubMed ID: 10800633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.